Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of an object from a flat X-ray image. GlobalData uses proprietary data and analytics to provide a comprehensive report on the computed tomography devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights New Zealand Computed Tomography Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2021, GlobalData’s Market Model methodology determined that the leading player in the computed tomography market in New Zealand was Siemens Healthineers followed by Philips Healthcare, GE Healthcare and Canon Medical Systems.

Computed Tomography (CT) is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with high risk of heart disease. It can also be used for image complex fractures, detect infarction, tumors, calcifications, hemorrhage and bone trauma and also acute and chronic changes in the lung parenchyma etc. The device includes a slice detector and an X-ray source. 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems, 20-40 slice CT Systems and 16-slice and below CT Systems are tracked under this category. Tracked here under is the equipment only and not accessories and/or additional costs associated with CT installation.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the computed tomography devices market within New Zealand was expected to be over $3m in 2021.

For the latest complete market share analysis of computed tomography device market in New Zealand, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.